drugset / Trial / NCT00416039

Efficacy of Sublingual Midazolam in Association With Oral Morphine in Children Analgesia After Bone Fracture

NCT00416039

RandomizedParallel-groupDouble-blindTreatment

Summary

It is a randomized simple-blind monocentric study; the group A will receive oral morphine with placebo and the group B will receive oral morphine with sublingual midazolam. The aim of this study is to show a more important pain decrease in the group taking midazolam versus placebo.

Timeline

Start
2007-01
Primary completion
2008-11
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.2 mg/kg Other
Background Morphine Other / unclassified 0.5 mg/kg Oral

Indications

No indication recorded.